Trending...
- "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
- Australian Brand Highlights the Rise of "Micro-Prepping"
- Deep Learning Robotics (DLRob) Announces Pre-Launch of Zero-Teach and Teach-by-Demonstration Technology for Kitting Applications
Western Australian researchers have discovered the genetic cause of a rare muscle disease that causes muscle weakness, droopy eyelids and difficulty swallowing.
NEDLANDS, Australia - AussieJournal -- Researchers at the Harry Perkins Institute of Medical Research and The University of Western Australia (UWA) have discovered the genetic cause of a rare muscle disease that causes muscle weakness, droopy eyelids and difficulty swallowing.
The disease, known as oculopharyngodistal myopathy (OPDM), is an inherited muscle disease. Genes associated with OPDM had only been identified previously in Asian populations.
This week, Perkins researchers in the Rare Disease Genetics and Functional Genomics Group (https://perkins.org.au/research/labs/genome-bio...), led by Associate Professor Gina Ravenscroft (https://perkins.org.au/person/gina-ravenscroft-2/), and the Preventative Genetics Group (https://perkins.org.au/research/labs/genome-bio...), led by Emeritus Professor Nigel Laing AO, published findings from an international world-leading study that identified the genetic cause of OPDM in people of European descent.
More on Aussie Journal
The researchers discovered that a specific type of mutation, an expansion of a repeat sequence, in the ABCD3 gene triggers a cascade of cellular issues that ultimately leads to muscle degeneration. These repeat expansions have been difficult to pinpoint, but new technologies and computer tools have enabled researchers to more easily find these repeat expansions that cause disease.
"It is so important to study genetic variations across different populations. Discovering that the ABCD3 gene was the cause of OPDM in Europeans adds to the understanding of this disease and opens the door for researchers to explore potential treatments for this and similar muscle diseases," Associate Professor Gina Ravenscroft said.
"Identifying disease-causing genes for families is so rewarding, often families experience these life-changing symptoms and many never get answers about the cause of their disorder. For some families this has ended a very long diagnostic odyssey, with DNA samples first received almost 30 years ago."
More on Aussie Journal
There are more than 10,000 distinct rare diseases, 70% of which start in childhood. Most of these diseases have a genetic origin, and families must rely on medical researchers to find the disease-gene needle in their DNA haystack.
"Rare diseases impact around 1 in 10 people and these families can go a lifetime without answers. By finding the genetic cause, we can give families a better understanding of the disease progression, their likelihood of passing it on, and importantly it offers the possibility of finding new treatments or cures one day," Associate Professor Ravenscroft said.
The study was published this week in Nature Communications. (https://www.nature.com/articles/s41467-024-49950-2)
The disease, known as oculopharyngodistal myopathy (OPDM), is an inherited muscle disease. Genes associated with OPDM had only been identified previously in Asian populations.
This week, Perkins researchers in the Rare Disease Genetics and Functional Genomics Group (https://perkins.org.au/research/labs/genome-bio...), led by Associate Professor Gina Ravenscroft (https://perkins.org.au/person/gina-ravenscroft-2/), and the Preventative Genetics Group (https://perkins.org.au/research/labs/genome-bio...), led by Emeritus Professor Nigel Laing AO, published findings from an international world-leading study that identified the genetic cause of OPDM in people of European descent.
More on Aussie Journal
- Chasefive Named MarTech Innovator of the Year 2026 at the Australian Enterprise Awards
- Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
- FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
- $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
- CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
The researchers discovered that a specific type of mutation, an expansion of a repeat sequence, in the ABCD3 gene triggers a cascade of cellular issues that ultimately leads to muscle degeneration. These repeat expansions have been difficult to pinpoint, but new technologies and computer tools have enabled researchers to more easily find these repeat expansions that cause disease.
"It is so important to study genetic variations across different populations. Discovering that the ABCD3 gene was the cause of OPDM in Europeans adds to the understanding of this disease and opens the door for researchers to explore potential treatments for this and similar muscle diseases," Associate Professor Gina Ravenscroft said.
"Identifying disease-causing genes for families is so rewarding, often families experience these life-changing symptoms and many never get answers about the cause of their disorder. For some families this has ended a very long diagnostic odyssey, with DNA samples first received almost 30 years ago."
More on Aussie Journal
- PRÝNCESS Builds Anticipation With "My Nerves" — A Girls-Girl Anthem
- Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
- From Sleepless Nights to Sold-Out Drops: Catch Phrase Poet's First Year Redefining Motivational Urban Apparel
- Cold. Clean. Anywhere. Meet FrostSkin
- How Specialized Game Development Services Are Powering the Next Wave of Interactive Entertainment
There are more than 10,000 distinct rare diseases, 70% of which start in childhood. Most of these diseases have a genetic origin, and families must rely on medical researchers to find the disease-gene needle in their DNA haystack.
"Rare diseases impact around 1 in 10 people and these families can go a lifetime without answers. By finding the genetic cause, we can give families a better understanding of the disease progression, their likelihood of passing it on, and importantly it offers the possibility of finding new treatments or cures one day," Associate Professor Ravenscroft said.
The study was published this week in Nature Communications. (https://www.nature.com/articles/s41467-024-49950-2)
Source: Harry Perkins Institute of Medical Research
0 Comments
Latest on Aussie Journal
- Hubble Tension Solved? Study finds evidence of an 'Invisible Bias' in How We Measure the Universe
- Boonuspart.ee Acquires Kasiino-boonus.ee to Strengthen Its Position in the Estonian iGaming Market
- Vines of Napa Launches Partnership Program to Bolster Local Tourism and Economic Growth
- Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
- Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season
- "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
- Patron Saints Of Music Names Allie Moskovits Head Of Sync & Business Development
- Tory Papa Positions Eastern Suburbs Cleaning Group as Leading Commercial Cleaning Authority Across
- Dave Aronberg Named 2026 John C. Randolph Award Recipient by Palm Beach Fellowship of Christians & Jews
- General Relativity Challenged by New Tension Discovered in Dark Siren Cosmology
- New Global Online Maths Challenge Opens for Primary & Middle School Students
- Unseasonable Warmth Triggers Early Pest Season Along I-5 Corridor
- Bug Busters Expands Service Footprint With New Carrollton, Georgia Branch
- Why KULR Could Be a Quiet Enabler of Space-Based Solar Power (SBSP) Over The Long Term: KULR Technology Group, Inc. (NY SE American: KULR)
- Why Finland Had No Choice But to Legalize Online Gambling
- High-Margin Energy & Digital Infrastructure Platform Created after Merger with Established BlockFuel Energy, Innovation Beverage Group (NAS DAQ: IBG)
- iFLO Pro Launches Its Groundbreaking iFLO Pro Mini At The 2026 AHR Expo In Las Vegas
- TL International Group Becomes First Global Operator to Fully Migrate to Pulsant's Dedicated Car Rental Cloud
- Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways
- Australian Brand Highlights the Rise of "Micro-Prepping"